We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$271M
AUM Growth
+$60.3M
Cap. Flow
+$47.9M
Cap. Flow %
17.67%
Top 10 Hldgs %
13.08%
Holding
692
New
310
Increased
37
Reduced
52
Closed
292

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$8.81M
2
AYI icon
Acuity Brands
AYI
+$3.97M
3
MDLZ icon
Mondelez International
MDLZ
+$3.21M
4
COST icon
Costco
COST
+$3.2M
5
BUD icon
AB InBev
BUD
+$2.45M

Top Sells

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$6.58M
2
AMGN icon
Amgen
AMGN
+$2.37M
3
DHR icon
Danaher
DHR
+$2.23M
4
LOW icon
Lowe's Companies
LOW
+$2.06M
5
V icon
Visa
V
+$2.05M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.84%
2 Technology 17.76%
3 Healthcare 12.81%
4 Industrials 12.03%
5 Consumer Staples 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANSS
151
DELISTED
Ansys
ANSS
$623K 0.23%
5,117
+1,917
+60% +$226K
OPLN
152
Openlane
OPLN
$4.25B
$617K 0.23%
+38,837
New +$632K
WAT icon
153
Waters Corp
WAT
$36.4B
$613K 0.23%
+3,334
New +$579K
AGO icon
154
Assured Guaranty
AGO
$3.78B
$605K 0.22%
14,500
-2,300
-14% -$90.6K
MYGN icon
155
Myriad Genetics
MYGN
$515M
$594K 0.22%
23,000
-7,100
-24% -$151K
HSIC icon
156
Henry Schein
HSIC
$9.64B
$587K 0.22%
8,186
-994
-11% -$69.3K
AMAT icon
157
Applied Materials
AMAT
$410B
$582K 0.21%
+14,100
New +$599K
KEY icon
158
KeyCorp
KEY
$24.1B
$575K 0.21%
+30,700
New +$555K
D icon
159
Dominion Energy
D
$61.8B
$574K 0.21%
+7,494
New +$589K
RRGB icon
160
Red Robin
RRGB
$136M
$568K 0.21%
+8,700
New +$552K
WCN
161
Waste Connections
WCN
$42.7B
$567K 0.21%
+8,800
New +$547K
PRXL
162
DELISTED
Parexel International Corp
PRXL
$565K 0.21%
+6,500
New +$485K
IRBT
163
DELISTED
iRobot
IRBT
$564K 0.21%
+6,700
New +$578K
BBWI icon
164
Bath & Body Works
BBWI
$4.13B
$563K 0.21%
+12,934
New +$530K
PFPT
165
DELISTED
Proofpoint, Inc.
PFPT
$562K 0.21%
+6,469
New +$532K
DOX icon
166
Amdocs
DOX
$5.64B
$561K 0.21%
+8,700
New +$549K
UAA icon
167
Under Armour
UAA
$3.02B
$555K 0.2%
+25,500
New +$519K
FINL
168
DELISTED
Finish Line
FINL
$553K 0.2%
+39,018
New +$566K
CSRA
169
DELISTED
CSRA Inc.
CSRA
$553K 0.2%
+17,433
New +$522K
BR icon
170
Broadridge
BR
$17.7B
$552K 0.2%
+7,300
New +$527K
CSX icon
171
CSX Corp
CSX
$96B
$551K 0.2%
+30,300
New +$519K
DD
172
DELISTED
Du Pont De Nemours E I
DD
$549K 0.2%
+6,800
New +$544K
MA icon
173
Mastercard
MA
$487B
$543K 0.2%
+4,467
New +$530K
GPC icon
174
Genuine Parts
GPC
$17.6B
$536K 0.2%
+5,777
New +$531K
BOX icon
175
Box
BOX
$4.18B
$534K 0.2%
+29,274
New +$528K

Similar funds

Bayesian Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Bayesian Capital Management held 692 positions worth $271M, up 29% from $211M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bayesian Capital Management deployed $47.9M of net new capital in Q2 2017, opening 310 new positions and adding to 37 existing holdings. Its largest new stake was Nike: 163,400 shares worth $9.64M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Visa, an estimated $2.05M trimmed.

  • Bayesian Capital Management's largest Q2 2017 buy was Nike: 163,400 shares worth $9.64M.
  • Bayesian Capital Management added most to Mondelez International in Q2 2017, an estimated $3.21M increase.
  • Bayesian Capital Management's biggest Q2 2017 reduction was Visa, cutting an estimated $2.05M.
  • Bayesian Capital Management fully exited Red Hat Inc in Q2 2017, selling an estimated $6.58M.
  • Bayesian Capital Management's ten largest holdings make up 13% of its $271M portfolio in Q2 2017.
  • Bayesian Capital Management opened 310 new positions and closed 292 in Q2 2017.
  • Bayesian Capital Management's portfolio value rose 29% quarter-over-quarter to $271M.

Based on Bayesian Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.